The global ePharmacy market was valued at USD 60.0 billion in 2022 and is projected to grow at a robust compound annual growth rate (CAGR) of 20.4% from 2023 to 2030. Several key factors are driving this growth, including the expanding global internet penetration, the digitalization of healthcare services, and a growing base of tech-savvy consumers. These factors are collectively enhancing the accessibility and appeal of ePharmacy platforms, thereby fueling market expansion. Additionally, there is a noticeable shift in consumer behavior, with more people opting for the convenience of online purchasing, further supporting the growth of the market.

The growing adoption of digital technologies and e-commerce within the healthcare sector is expected to significantly contribute to the overall expansion of ePharmacy. The ongoing digital transformation in healthcare is not only making services more accessible but also more efficient, which is likely to drive future growth in the ePharmacy sector.

Gather more insights about the market drivers, restrains and growth of the ePharmacy Market

The growing pressures in the healthcare sector, including rising operational costs, have led to a shift towards more cost-efficient solutions like ePharmacy. As healthcare providers face increasing financial strain, they are increasingly turning to ePharmacy solutions to streamline operations and reduce overhead costs. This, combined with the rising prevalence of chronic conditions, is driving a higher demand for pharmaceutical products. As a result, more consumers are turning to online platforms for the procurement of drugs, further boosting the penetration of ePharmacy services across the globe.

Regional Insights

North America ePharmacy Market Trends

North America dominated the global ePharmacy market with a substantial market share of over 40.4% in 2022. Several key factors are driving the growth of ePharmacy in the region. These include the rising adoption of e-commerce, an aging population, a growing preference for online shopping, a well-established healthcare infrastructure, and a positive attitude towards adopting new technologies. Collectively, these factors have significantly contributed to the region’s leadership in the ePharmacy market. In particular, about 80% of the U.S. population is now connected to ePharmacy platforms, highlighting the widespread acceptance and integration of these services. Additionally, the region is witnessing a shift towards the direct-to-patient model, which offers convenience and faster access to medications.

The digital transformation of healthcare is creating a more consumer-friendly environment, further driving market expansion. North American consumers are increasingly looking for convenient, online healthcare solutions that offer advanced services like teleconsultation and home delivery. This shift is exemplified by significant industry moves, such as Medicure Inc.'s announcement in December 2020 to acquire 100% of Marley Drug, Inc. through its U.S. subsidiary, Medicure Pharma Inc. This acquisition highlights the growing importance of ePharmacy in providing accessible, affordable healthcare services.

The COVID-19 pandemic has also had a profound impact on consumer behavior, accelerating the demand for online pharmaceutical services. The pandemic prompted more people than ever to seek medicines and healthcare-related products through ePharmacy platforms. In line with this, in April 2022, Walgreens and Wing launched a drone delivery pilot program in the first large urban region of the U.S., aiming to offer faster, more efficient delivery options for ePharmacy customers.

Asia Pacific ePharmacy Market Trends

Asia Pacific is expected to register the fastest compound annual growth rate (CAGR) during the forecast period. Emerging economies, particularly China and India, present significant growth potential for the ePharmacy market due to their large populations and growing government initiatives that promote the adoption of digital technologies. These initiatives are creating a more favorable environment for ePharmacy platforms to thrive.

In addition, both public and private organizations in Asia Pacific are taking strategic steps to boost the market's expansion. For example, in August 2020, Reliance Retail, one of India’s largest retail companies, acquired a 60% equity stake in Netmeds for USD 83 million. This acquisition is expected to enhance Reliance’s ability to offer affordable and high-quality healthcare products and services to its customers, further fueling the region's ePharmacy market.

Another significant development in Asia Pacific occurred in January 2022 when Hyphens Pharma International Limited, Singapore’s largest specialty pharmaceutical and consumer healthcare company, launched WellAway, an ePharmacy service. WellAway aims to provide customers with easy access to pharmaceutical services and teleconsultation, a service that has become increasingly important during the COVID-19 pandemic. The platform is especially beneficial for elderly, immobile, or self-isolating patients, offering them a convenient way to obtain healthcare services without having to leave their homes.

Browse through Grand View Research's Category Healthcare IT Industry Research Reports.

• The global AI in oncology market size was estimated at USD 2.80 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 28.92% from 2024 to 2030.  

• The global population health management market sizewas estimated at USD 70.0 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 22.0% from 2024 to 2030. 

Key Companies & Market Share Insights

To strengthen their position in the ePharmacy market and expand their market share, key players in the industry employ a variety of marketing and growth strategies. These strategies often include mergers, acquisitions, partnerships, and innovative marketing campaigns that help companies differentiate themselves from competitors and reach a broader customer base.

One significant move occurred in January 2019, when The Zur Rose Group, a prominent European ePharmacy player, completed the acquisition of the e-commerce operations of medpex, which is Germany's third-largest online pharmacy. This acquisition allowed the Zur Rose Group to significantly enhance its market presence in Germany, one of the largest pharmaceutical markets in Europe. The acquisition not only bolstered Zur Rose's share in the country but also helped the company expand its customer base and diversify its product offerings.

These strategic actions demonstrate how key companies in the ePharmacy market are actively seeking to expand their market share, diversify their services, and improve customer experience by forming strategic alliances, acquiring established businesses, and exploring innovative new models of service delivery.

Some prominent players in the global ePharmacy market include:

• The Kroger Co.
• Walgreen Co.
• Giant Eagle, Inc.
• Walmart, Inc.
• Express Scripts Holding Company
• CVS Health
• Optum Rx, Inc.
• Rowlands Pharmacy
• DocMorris (Zur Rose Group AG)
• Cigna Corporation (Express Scripts Holdings)
• Amazon.com Inc.
• Axelia Solutions (Pharmeasy)
• Apex Healthcare Berhad (Apex Pharmacy)
• Apollo Pharmacy
• Netmeds

Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.